Medication adherence in type 2 diabetes patients in Nigeria

Diabetes Technology & Therapeutics
Idongesit L JacksonChinwe V Ukwe

Abstract

Medication adherence is a major universal factor influencing patient health outcomes, particularly in chronic diseases such as diabetes. Poor adherence to antidiabetes medication can cause therapeutic failure, leading to manifestation of diabetes-related complications, such as retinopathy, neuropathy, nephropathy, etc., reduced quality of life, and increased healthcare costs. To forestall these, likely predictors of medication nonadherence should be assessed and addressed appropriately. The purpose of this work was therefore to assess medication adherence among type 2 diabetes patients and to identify patient characteristics and probable factors associated with nonadherence. A descriptive, cross-sectional research design was used. The study was conducted on 360 ambulatory type 2 diabetes patients attending an endocrinology clinic between June 2012 and February 2013. The eight-item Modified Morisky Adherence Scale was used to assess medication adherence; sociodemographic information and respondents' opinion on the possible barrier(s) to medication adherence were also obtained. Data were analyzed using SPSS version 14.0 software (SPSS, Inc., Chicago, IL). Of the 303 patients included in the final analysis, 19.8% of respondents we...Continue Reading

References

Mar 1, 1987·Southern Medical Journal·A K DiehlN J Sugarek
Nov 23, 2000·Archives of Internal Medicine·P S CiechanowskiJ E Russo
Dec 26, 2001·Journal of Clinical Epidemiology·J H WagnerUNKNOWN VACS 3 Project Team
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 12, 2003·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Sabina De Geest, Eduardo Sabaté
Mar 12, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Mary V SpiersMeilissa Lamar
Apr 28, 2004·Diabetes Care·Robert D GoldneyDavid H Wilson
Jul 9, 2004·The Annals of Pharmacotherapy·Kimberley KrapekTeresa J Lubowski
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Apr 24, 2008·JAMA : the Journal of the American Medical Association·Jeanne M MaddenStephen B Soumerai
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Sep 12, 2008·Pharmacy World & Science : PWS·Kazeem B YusuffBonatson Y Joseph
May 12, 2009·Journal of the American Board of Family Medicine : JABFM·Jeanette M DalyRobert E Garrett
Mar 2, 2011·Journal of Family & Community Medicine·Nahla Khamis R IbrahimFatihey El-Sewi
Nov 16, 2011·International Journal of Clinical Pharmacy·Harith Kh Al-QazazFahad Saleem
Feb 10, 2012·The Diabetes Educator·Genee R BaileyNathan D Pope
Mar 1, 2012·North American Journal of Medical Sciences·Nasir T WabeSadikalmahdi Hussein
Nov 14, 2014·BMC Health Services Research·Clarissa HsuChristopher L Bryson

❮ Previous
Next ❯

Citations

May 28, 2019·Archives of public health = Archives belges de santé publique·Laleh Dehdari, Tahereh Dehdari
Oct 1, 2018·BMC Public Health·Victor StephaniDavid Beran
Apr 23, 2021·International Journal of Clinical Practice·Sawsan KurdiAshraful Islam

❮ Previous
Next ❯

Software Mentioned

Excel
Statistical Package for the Social Sciences ( SPSS )

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.